查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1860102

腦血管血管造影術市場按設備類型、操作模式、應用和最終用戶分類 - 全球預測 2025-2032 年

Cerebral Angiography Market by Equipment Type, Operation Mode, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腦血管造影術市場規模將達到 26.1 億美元，複合年成長率為 7.05%。

主要市場統計數據
基準年 2024 15.1億美元
預計年份：2025年 16.2億美元
預測年份：2032年 26.1億美元
複合年成長率 (%) 7.05%

對腦血管造影術的目的和臨床意義，以及影像學和介入治療在現代神經血管醫學中的整合進行權威說明

腦血管造影術在現代神經血管醫學中發揮核心作用，因為它能夠直接觀察顱內和顱外血管結構，從而進行診斷和治療性介入。儘管成像技術不斷進步，但腦血管造影在包括急性中風治療、動脈瘤檢測和治療方案製定、血管畸形評估以及複雜介入神經放射學手術在內的多種臨床應用中仍然至關重要。診斷清晰度和操作便利性之間的平衡是臨床決策的基礎，並推動對設備設計和影像軟體的持續投入。

快速的技術進步、流程最佳化和不斷發展的診療路徑如何重塑腦血管造影術的實踐和採購趨勢

腦血管造影術領域正經歷一場變革，其驅動力來自於技術進步、手術通訊協定的改進以及醫療體系的重組。數位影像處理和即時處理技術的進步使得低劑量、高解析度血管造影術成為可能，從而顯著提升了手術安全性和醫生的操作水平。與硬體創新同步，軟體的進步——尤其是自動化、血管分割和3D重建技術——正在提高手術效率，並支援在複雜介入手術中實現更精準的導航。

評估2025年美國關稅對腦血管造影術供應鏈、採購行為和臨床連續性的系統性影響

美國在2025年推出和調整的關稅將對腦血管血管造影術生態系統產生累積影響，其影響遠不止於即時的成本增加。關稅壓力將推高進口成像組件、檢測器、精密導管及相關耗材的到岸成本，迫使採購團隊重新評估其供應商組合。為此，一些製造商將探索本地生產、對國內供應商進行資格認證，或重新設計其供應鏈以減少對關稅敏感領域的依賴。這些調整需要時間和投資，但最終可能增強其抵禦貿易政策波動的能力。

設備類型、運作模式、臨床應用和最終用戶環境的不同策略需求會影響技術採納和採購決策。

該分析重點闡述了技術應用、營運需求和最終用戶優先順序的關鍵差異。依設備類型分類，市場分為固定式和移動式。固定式系統通常安裝在專用血管造影術室，優先考慮持續高吞吐量、先進的軟體模組以及與外科和加護治療團隊的整合。而移動式設備則優先考慮便攜性、在混合手術室的快速部署以及跨多個手術區域的靈活排班。依運作模式分類，市場分為類比式和數位式。雖然類比平台仍在一些傳統環境中運作，但由於數位系統具有卓越的影像處理、劑量管理以及與電子健康記錄的無縫整合，因此在新投資中佔據主導地位。按應用分類，市場分為診斷和治療性介入場景。診斷應用場景優先考慮用於病灶表徵的影像清晰度和工作流程效率，而治療性介入應用場景則需要強大的設備相容性、先進的導航工具和即時影像處理能力來支援治療操作。依最終用戶分類，市場分為門診手術中心和醫院。醫院又進一步細分為私立醫院和公立醫院。日間手術中心正在擴大特定手術的門診介入項目，私立醫院經常投資先進技術來支持重症患者網路，而公立醫院則在有限的資本預算和廣泛的就醫途徑之間尋求平衡，優先考慮耐用、可維護的系統來支持大量的患者。

不同地區醫療模式和基礎設施的差異會影響採購重點、臨床應用和供應商策略。

區域趨勢影響著三大關鍵區域的採購重點、法規環境和臨床應用模式。在美洲，醫療系統日益重視整合網路和快速中風通報管道，促使醫療系統投資建造高通量血管造影術室，並加強急診醫學、神經內科和介入治療團隊之間的協作。報銷機制和資本規劃實踐鼓勵將高級服務集中在指定的專科中心，而門診則面臨越來越多的低複雜度介入治療病例。

供應商的關鍵競爭重點包括模組化硬體、透過軟體簡化臨床工作流程、強調卓越的服務品質以及深化與醫療服務提供者的夥伴關係。

腦血管血管造影術設備領域的競爭主要集中在影像硬體創新、軟體主導的工作流程最佳化以及能夠降低供應商整體擁有成本的綜合服務模式。主要企業越來越重視模組化系統結構，這種架構允許檢測器和處理單元逐步升級，從而延長設備使用壽命，減少系統整體更換的需求。同時，從自動血管分割到手術規劃和整合報告等軟體功能正成為影響採購決策和長期供應商合作關係的關鍵差異化因素。

產業相關人員可以採取切實有效、影響深遠的策略措施，以加強供應鏈韌性、加速數位化能力建構並提升臨床夥伴關係。

行業領導者可以採取果斷措施來維持臨床相關性和營運韌性。首先，他們應優先考慮供應鏈多元化和關鍵零件的雙重採購，以降低貿易政策變化和單一故障點帶來的風險。投資於區域製造夥伴關係和靈活的物流可以縮短前置作業時間並提高服務的可預測性。其次，他們應透過整合先進的影像處理、劑量最佳化和互通性標準，並促進無縫的電子健康記錄連接和手術報告，加快整個影像平台的數位轉型。

嚴謹的混合調查方法結合了文獻綜述、法規審查、專家訪談和比較工具分析，確保了研究結果的可靠性和可操作性。

本研究綜合了同儕審查臨床文獻、監管申報文件、醫療設備技術規範和已發布政策文件的系統性回顧證據，並輔以對介入神經放射學、放射科主任、醫療設備工程師和採購負責人的結構化訪談。資料收集優先考慮目前的操作指南、裝置安全建議以及影像引導介入的同儕審查分析，以確保臨床準確性和相關性。受訪者的選擇旨在代表門診手術中心和醫院環境中各類最終用戶，從而能夠對操作挑戰和推廣促進因素進行三角驗證。

本文簡要概述了技術進步、供應彈性和細分驅動策略如何匯聚起來，以維持和發展腦血管造影術。

腦血管血管造影術兼具診斷準確性與治療能力，是現代神經血管醫學的基石。數位影像、軟體驅動的工作流程以及導管設計的進步，使得手術更加安全高效，並拓展了血管造影術的臨床應用範圍。然而，貿易政策的波動和區域基礎設施的差異等外部壓力，凸顯了建構適應性強的供應鏈和服務模式的必要性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧演算法整合到腦血管造影術中，用於自動血管分割和異常檢測
  • 微創微導管技術在複雜顱內動脈瘤治療的應用日益廣泛
  • 我們正在擴建混合血管造影術設備，將錐狀射束CT和數位減影血管造影術結合，以進行全面的神經血管評估。
  • 透過實施輻射劑量降低通訊協定和即時影像軟體，提高腦血管造影術中的病患安全性。
  • 造影增強 4D 流成像技術越來越受到青睞，用於評估腦血管疾病的血流動力學模式。
  • 在急診中風照護環境中，對攜帶式照護現場血管造影術系統的需求日益成長。
  • 開發具有改進黏度特性的生物相容性造影劑，以減少介入神經放射學手術期間的不良反應

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依裝置類型分類的腦血管造影術市場

  • 固定類型
  • 移動的

9. 依操作模式分類的腦血管造影術市場

  • 模擬
  • 數位的

第10章 依應用分類的腦血管造影術市場

  • 診斷
  • 介入治療

第11章 以最終用戶分類的腦血管造影術市場

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院

第12章：腦血管造影術市場區域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 腦血管造影術市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國腦血管造影術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Siemens Healthineers AG
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Bracco Imaging SpA
    • Bayer AG
    • Guerbet SA
    • Terumo Corporation
    • Medtronic plc
    • Stryker Corporation
Product Code: MRR-8E22B619330B

The Cerebral Angiography Market is projected to grow by USD 2.61 billion at a CAGR of 7.05% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.51 billion
Estimated Year [2025] USD 1.62 billion
Forecast Year [2032] USD 2.61 billion
CAGR (%) 7.05%

An authoritative orientation to cerebral angiography objectives, clinical importance, and the convergence of imaging and interventional care in modern neurovascular practice

Cerebral angiography occupies a central role in modern neurovascular medicine by enabling direct visualization of intracranial and extracranial vasculature for both diagnosis and intervention. As imaging modalities evolve, the procedure maintains clinical relevance across acute stroke management, aneurysm detection and treatment planning, vascular malformation assessment, and complex neurointerventional procedures. The interplay between diagnostic clarity and procedural access underpins clinical decision-making and continues to drive investments in both device design and imaging software.

Clinicians value cerebral angiography for its spatial and temporal resolution and for the therapeutic window it provides when interventional approaches are indicated. Innovations in catheter technology, contrast media protocols, x-ray detector sensitivity, and digital image processing have collectively improved procedural safety and efficacy. Consequently, hospital systems and ambulatory surgical centers are recalibrating care pathways to integrate angiographic capabilities into stroke hubs and tertiary neurovascular centers, thereby enabling faster triage and more precise therapeutic delivery.

How rapid technological advances, procedural optimization, and evolving care pathways are reshaping cerebral angiography practice and procurement dynamics

The cerebral angiography landscape is in the midst of transformative shifts driven by technological progress, procedural protocol refinement, and health system-level reconfiguration. Advances in digital imaging and real-time processing now enable higher-resolution angiographic runs with lower radiation dose, which has immediate implications for procedural safety and operator practice. Parallel to hardware innovation, software enhancements-particularly in automation, vessel segmentation, and three-dimensional reconstructions-are increasing procedural efficiency and supporting more accurate navigation during complex interventions.

Beyond technology, clinical pathways have adjusted in response to the pressing need for faster reperfusion in ischemic stroke, leading to more integrated triage systems and streamlined transfer protocols between facilities. These operational changes increase demand for nimble angiography solutions that can be deployed across a range of settings while maintaining high-quality imaging. At the same time, regulatory emphasis on patient safety and device interoperability is prompting manufacturers to prioritize modular, upgradable architectures and to pursue certifications that facilitate cross-platform compatibility. Collectively, these shifts are reshaping investment priorities among providers and influencing procurement strategies across the care continuum.

Assessing the systemic consequences of United States tariff measures in 2025 on cerebral angiography supply chains, procurement behavior, and clinical continuity

The introduction and adjustment of tariffs by the United States in 2025 exert cumulative effects on the cerebral angiography ecosystem that extend beyond immediate cost implications. Tariff pressures raise the landed cost of imported imaging components, detectors, precision-engineered catheters, and ancillary disposables, which prompts procurement teams to reassess supplier portfolios. In turn, some manufacturers respond by seeking localized production, qualifying domestic suppliers, or redesigning supply chains to reduce exposure to tariff-sensitive nodes. These adaptations take time and investment but can ultimately increase resilience to trade policy volatility.

Operationally, facilities face extended lead times and potential substitution of components when preferred parts become subject to higher import duties. Clinicians and biomedical engineering teams must weigh the tradeoffs between short-term availability and long-term performance when selecting alternatives. Meanwhile, policy responses from trading partners and shifts in bilateral trade agreements can influence the flow of medical devices and components, adding another layer of uncertainty. In response, leading suppliers are accelerating dual-sourcing strategies and expanding regional distribution footprints to mitigate the cumulative effects of tariffs on clinical continuity and device support.

Differentiated strategic imperatives driven by equipment type, operation mode, clinical application, and end-user settings shaping technology adoption and procurement decisions

Segmentation-driven insight highlights meaningful differences in technology adoption, operational requirements, and end-user priorities. Based on Equipment Type, market is studied across Fixed and Mobile; Fixed systems, typically installed in dedicated angiography suites, emphasize sustained high throughput, advanced software modules, and integration with surgical and critical care teams, whereas Mobile units prioritize portability, rapid deployment within hybrid operating rooms, and flexible scheduling across multiple procedural areas. Based on Operation Mode, market is studied across Analog and Digital; analog platforms remain in service in some legacy environments but digital systems dominate new investments due to superior image processing, dose management, and seamless integration with electronic health records. Based on Application, market is studied across Diagnostic and Interventional; diagnostic use cases prioritize image clarity and workflow efficiency for lesion characterization, while interventional applications demand robust device compatibility, advanced navigation tools, and real-time imaging capabilities to support therapeutic maneuvers. Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals. The Hospitals is further studied across Private Hospitals and Public Hospitals; ambulatory surgical centers increasingly pursue outpatient interventional programs for selected procedures, private hospitals often invest in premium technology to support high-acuity referral networks, and public hospitals balance broad access with constrained capital planning, prioritizing durable, serviceable systems that support high patient volumes.

These segmentation perspectives reveal that procurement criteria differ across settings: fixed, high-volume suites favor system longevity and advanced imaging suites, while mobile and ambulatory contexts value compact footprint and rapid setup. Similarly, digitalization and interventional use cases accelerate demand for software-enabled workflows and vendor-supported training. Understanding these segmentation-based distinctions enables suppliers and providers to align product development, service models, and clinical training to the nuanced needs of each end-user type.

How distinct regional healthcare models and infrastructure variations across key geographies influence procurement priorities, clinical adoption, and supplier strategies

Regional dynamics influence procurement priorities, regulatory environments, and clinical utilization patterns across three broad geographies. In the Americas, health systems often focus on integrated networks and rapid stroke referral pathways, which incentivize investment in high-throughput angiography suites and close coordination between emergency medicine, neurology, and interventional teams. Reimbursement structures and capital planning practices encourage consolidation of advanced services in designated centers of excellence while ambulatory settings expand case portfolios for lower-complexity interventions.

In Europe, Middle East & Africa, the landscape presents heterogeneity driven by varied regulatory regimes, public versus private funding models, and infrastructure disparities. Many urban tertiary centers in this region pursue cutting-edge imaging upgrades and interventional program expansion, while regions with constrained resources prioritize durable platforms and remote support capabilities. In the Asia-Pacific region, rapid adoption of digital imaging, increasing investment in tertiary neurovascular programs, and a growing emphasis on domestic manufacturing and regulatory harmonization are notable trends. Across regions, suppliers adapt distribution and support strategies to meet differing clinical protocols, regulatory timelines, and capital procurement cycles, thereby shaping how technologies diffuse into practice.

Key competitive priorities for vendors emphasizing modular hardware, software-enabled clinical workflows, and service excellence to deepen provider partnerships

Competitive dynamics among companies servicing the cerebral angiography domain center on innovation in imaging hardware, software-driven workflow enhancements, and comprehensive service models that reduce total cost of ownership for providers. Leading firms increasingly prioritize modular system architectures that allow iterative upgrades to detectors and processing units, which supports longer equipment lifecycles and mitigates the need for full-system replacements. At the same time, software capabilities-ranging from automated vessel segmentation to procedural planning and integrated reporting-have become differentiating features that influence purchasing decisions and long-term vendor relationships.

Strategic partnerships between device manufacturers, software developers, and clinical centers are accelerating the translation of research into practice, enabling early validation of novel image-guided techniques. Service offerings that combine preventive maintenance, remote diagnostics, and expedited parts logistics are also central to company positioning, particularly for customers balancing procedural volume with constrained capital budgets. Overall, firms that demonstrate interoperability, robust clinical evidence, and responsive service networks tend to secure deeper integration within provider ecosystems and maintain stronger post-sale engagement.

Practical, high-impact strategic moves that industry stakeholders can implement to enhance supply resilience, accelerate digital capabilities, and strengthen clinical partnerships

Industry leaders can take decisive steps to sustain clinical relevance and operational resilience. First, prioritize supply chain diversification and dual-sourcing for critical components to reduce exposure to trade policy shifts and single points of failure. Investing in regional manufacturing partnerships and flexible logistics arrangements will shorten lead times and improve service predictability. Second, accelerate digital transformation across imaging platforms by integrating advanced image processing, dose optimization, and interoperability standards that facilitate seamless electronic health record connectivity and procedural reporting.

Third, align product development with evolving clinical workflows by supporting both diagnostic clarity and interventional utility; systems that bridge these needs will better serve integrated stroke and neurovascular programs. Fourth, strengthen post-sale relationships through outcome-focused service offerings, including remote monitoring, predictive maintenance, and clinician training programs that shorten learning curves for advanced procedures. Finally, engage proactively with health policy stakeholders to clarify regulatory pathways and to design reimbursement strategies that reflect the value of image-guided intervention, thereby enabling more sustainable adoption across diverse healthcare settings.

A rigorous, mixed-methods research approach combining literature, regulatory review, expert interviews, and comparative device analysis to ensure robust and actionable insights

This research synthesizes evidence from a systematic review of peer-reviewed clinical literature, regulatory filings, device technical specifications, and publicly available policy documents, supplemented by structured interviews with practicing neurointerventionalists, radiology department leaders, biomedical engineers, and procurement professionals. Data collection prioritized recent procedural guidelines, device safety advisories, and peer-reviewed analyses of image-guided interventions to ensure clinical accuracy and relevance. Interview subjects were selected to represent a cross-section of end users across ambulatory surgical centers and hospital settings, enabling triangulation of operational challenges and adoption drivers.

Analytic methods combined qualitative thematic analysis of interview data with comparative evaluation of device features and post-market surveillance reports. Segmentation frameworks were applied to evaluate how equipment type, operation mode, application, and end-user setting influence procurement criteria and clinical workflows. Throughout the research process, findings underwent independent expert validation to ensure robustness, and limitations related to data availability and regional heterogeneity were explicitly documented to guide interpretation and application of the insights.

A concise synthesis of how technological progress, supply resilience, and segmentation-aligned strategies converge to sustain and advance cerebral angiography practice

Cerebral angiography remains a cornerstone of modern neurovascular care, positioned at the intersection of diagnostic precision and therapeutic capability. Technological advancements in digital imaging, software-enabled workflows, and catheter design are enabling safer, more efficient procedures while simultaneously expanding the clinical settings in which angiography can be deployed. However, external pressures such as trade policy shifts and regional infrastructure variability underscore the need for adaptable supply chains and service models.

Providers and suppliers that adopt a segmentation-aware approach-recognizing distinct requirements for fixed versus mobile systems, analog versus digital operation modes, diagnostic versus interventional applications, and differences among ambulatory centers and hospital types-will be best positioned to align investments with clinical and operational priorities. In short, the path forward demands coordinated action across technology innovation, supply chain resilience, and clinician-centered service delivery to ensure that angiographic capabilities continue to advance patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for automated vessel segmentation and anomaly detection in cerebral angiography
  • 5.2. Rising utilization of minimally invasive microcatheter technologies for complex intracranial aneurysm interventions
  • 5.3. Expansion of hybrid angiography suites combining cone beam CT and digital subtraction angiography for comprehensive neurovascular assessment
  • 5.4. Adoption of radiation dose reduction protocols and real-time imaging software to enhance patient safety in cerebral angiography
  • 5.5. Increasing preference for contrast-enhanced 4D flow imaging techniques to evaluate hemodynamic patterns in cerebrovascular disorders
  • 5.6. Growth in demand for portable and point-of-care angiography systems in emergency stroke intervention settings
  • 5.7. Development of biocompatible contrast agents with improved viscosity profiles to reduce adverse reactions during neurointerventional procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cerebral Angiography Market, by Equipment Type

  • 8.1. Fixed
  • 8.2. Mobile

9. Cerebral Angiography Market, by Operation Mode

  • 9.1. Analog
  • 9.2. Digital

10. Cerebral Angiography Market, by Application

  • 10.1. Diagnostic
  • 10.2. Interventional

11. Cerebral Angiography Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals

12. Cerebral Angiography Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cerebral Angiography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cerebral Angiography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Siemens Healthineers AG
    • 15.3.2. GE HealthCare Technologies Inc.
    • 15.3.3. Koninklijke Philips N.V.
    • 15.3.4. Canon Medical Systems Corporation
    • 15.3.5. Bracco Imaging S.p.A.
    • 15.3.6. Bayer AG
    • 15.3.7. Guerbet S.A.
    • 15.3.8. Terumo Corporation
    • 15.3.9. Medtronic plc
    • 15.3.10. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CEREBRAL ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 79. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 83. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 85. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 94. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 96. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 106. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 112. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 142. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 148. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 160. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 180. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 181. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 186. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 187. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 192. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 193. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 198. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 216. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 217. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 228. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 229. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 234. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 235. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 240. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 241. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 253. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 259. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 262. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 263. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 268. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 269. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 272. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 273. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 278. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 279. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 282. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 283. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 299. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 302. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 303. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 308. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 309. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 312. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 313. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 318. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 319. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 322. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 323. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 328. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 329. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 332. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 333. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 337. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 338. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 339. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2024 (USD MILLION)
  • TABLE 342. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025-2032 (USD MILLION)
  • TABLE 343. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 344. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLIO